Harshvinder Bhullar

An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance

Xiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar et al. · Drug Safety · 2013 · 82 citations

Drug Safety, Health Informatics, Engineering +11

Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility

Donna R. Rivera, Mugdha Gokhale, Matthew W. Reynolds et al. · Pharmacoepidemiology and Drug Safety · 2020 · 36 citations

Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

Vincent Lo Re, Kevin Haynes, Eileen E. Ming et al. · Pharmacoepidemiology and Drug Safety · 2012 · 23 citations

Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)

Dena M. Carbonari, M. Elle Saine, Craig Newcomb et al. · Pharmacoepidemiology and Drug Safety · 2015 · 21 citations

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes

Vincent Lo Re, Dena M. Carbonari, M. Elle Saine et al. · BMJ Open Diabetes Research & Care · 2017 · 20 citations · Full text